<DOC>
	<DOCNO>NCT01672164</DOCNO>
	<brief_summary>The main focus study develop blood and/or urine test help detect early sign rejection people liver transplant . Researchers examine blood , urine , tissue sample try identify marker certain condition rejection , response therapy , scar liver . Additionally , researcher would like identify biomarkers detect damage native kidney blood level creatinine rise . By study gene expression , researcher hope able diagnose condition earlier improve liver survival .</brief_summary>
	<brief_title>Discovery Validation Proteogenomic Biomarker Panels Liver Transplant Recipients</brief_title>
	<detailed_description />
	<criteria>Subjects undergoing primary deceaseddonor live donor liver transplantation ; Subject must able understand provide inform consent . Need combine organ transplantation ; Previous solid organ and/or islet cell transplantation ; Infection HIV ; Allergy iodine ; Inability unwillingness participant comply study protocol ; Any condition , opinion investigator , would interfere participant 's ability comply study requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>proteogenomic biomarker panel</keyword>
</DOC>